NDC 66715-9749-03 - Excedrin Migraine, TRAVEL BASIX
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66715-9749
- Requested NDC
- 66715-9749-03
- Package NDCs from labels
- 66715-9749-3, 66715-9749-8, 66715-9749-2, 66715-9749-03
- Manufacturer
- Lil' Drug Store Products, Inc.
- Effective date
- 2024-12-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Excedrin ® Migraine Lil' Drug Store ® , TRAVEL BASIX, CVP ® HEALTH | Lil' Drug Store Products, Inc. | 2024-12-13 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 66715-9749-3 | 2022-07-29 | C162847 | 48780-1 | e4f33bdf-a78d-d8a0-e053-dadaa90a6e4e | Excedrin ® Migraine Lil' Drug Store ® , TRAVEL BASIX, CVP ® HEALTH |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66715-9749-2 | Excedrin Migraine | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 7 | |
| 66715-9749-2 | Excedrin Migraine | 2 in 1 CARTON | TABLET, FILM COATED | 2 | 7 | |
| 66715-9749-3 | Excedrin Migraine | 3 in 1 CARTON | TABLET, FILM COATED | 3 | 7 | |
| 66715-9749-3 | Excedrin Migraine | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 7 | |
| 66715-9749-8 | Excedrin Migraine | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 7 | |
| 66715-9749-8 | Excedrin Migraine | 30 in 1 BOX, UNIT-DOSE | TABLET, FILM COATED | 30 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 66715-9749 | EXCEDRIN MIGRAINE, TRAVEL BASIX (ACETAMINOPHEN, ASPIRIN, AND CAFFEINE) TABLET, FILM COATED EXCEDRIN MIGRAINE, CVP HEALTH (ACETAMINOPHEN, ASPIRIN, AND CAFFEINE) TABLET, FILM COATED EXCEDRIN MIGRAINE (ACETAMINOPHEN, ASPIRIN, AND CAFFEINE) TABLET, FILM COATED [LIL' DRUG STORE PRODUCTS, INC.] | 7 | Current NDC, Legacy NDC, 6 package rows | 20241215_40aeb2c5-a37b-446d-9918-8378a75ff327.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Target Maximum Strength Cold Flu and Sore Throat | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | TARGET CORPORATION | 1d3ad31f-ef4d-45ba-a6e3-13d66b51d1d2 | 2026-11-10 | Warnings | 362O9ITL9D |
| Cold Max | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | AmeriSource Bergen | 608e6808-29e4-40bc-8496-24c092681a1b | 2026-11-09 | Warnings | 362O9ITL9D |
| Pain Relief | ACETAMINOPHEN | Demoulas Super Markets, Inc | 39800c27-f39f-cd60-e063-6394a90acd55 | 2026-11-09 | Warnings | 362O9ITL9D |
| Pain Relief Extra Strength | ACETAMINOPHEN | SAFEWAY | d2d15e06-e9eb-3d2b-e053-2995a90a1cec | 2026-11-09 | Warnings | 362O9ITL9D |
| Pain Relief PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | Safeway | f9597abc-3f01-4b94-8078-228e0b74677e | 2026-11-09 | Warnings | 362O9ITL9D |
| Pain Relief (Arthritis) | PAIN RELIEF (ARTHRITIS) | Demoulas Super Markets, Inc. | 14a2abd2-0e64-4a8b-a979-cc19a3dbd525 | 2026-11-09 | Warnings | 362O9ITL9D |
| equate pain reliever | ACETAMINOPHEN, IBUPROFEN | WALMART INC. | 8e0aaae0-a97d-4b9d-b326-44ef45f3fa0c | 2026-11-08 | Warnings | 362O9ITL9D |
| Aspirin Low Dose | ASPIRIN | Strategic Sourcing Services LLC | 3c7883da-6f51-4716-b012-0e33d239a60e | 2026-11-06 | Warnings | R16CO5Y76E |
| Target Overnight Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, TRIPROLIDINE HCL | TARGET CORPORATION | 05e944d5-3473-4d8c-8df4-2ffc7474e9fa | 2026-11-06 | Warnings | 362O9ITL9D |
| Vicks NyQuil VapoCOOL COLD and FLU | ACETAMINOPHEN, DOXYLAMINE SUCCINATE, DEXTROMETHORPHAN HYDROBROMIDE | The Procter & Gamble Manufacturing Company | 32819305-9bbd-8843-e063-6294a90a7f2e | 2026-11-06 | Warnings | 362O9ITL9D |
| Children Pain and Fever Reliever | ACETAMINOPHEN | Target Corporation | 0dd643a4-3cbc-423d-95b4-ba373b09d895 | 2026-11-06 | Warnings | 362O9ITL9D |
| Children Pain and Fever Reliver | ACETAMINOPHEN | Target Corporation | 1116f808-f61e-47ec-b0d0-d4be5aa905be | 2026-11-06 | Warnings | 362O9ITL9D |
| Tukol Childrens Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Genomma Lab USA | aa685658-953e-4307-996c-ee39ca6bf9ba | 2026-11-06 | Warnings | 362O9ITL9D |
| Sinus Pressure, Pain and Cough | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Meijer Distribution, Inc. | f701a6ae-200d-48dc-94e4-6bd3228f50d4 | 2026-11-05 | Warnings | 362O9ITL9D |
| Aspirin Low Dose | ASPIRIN | L.N.K. International, Inc. | 39e142a7-8590-4e1e-8319-6904fb57cc8a | 2026-11-05 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | Bi-Mart | cc5db55a-a2b0-48f4-802b-9e5e94fd9ceb | 2026-11-05 | Warnings | R16CO5Y76E |
| Foster and Thrive Regular Strength Pain Relief Acetaminophen 325mg | ACETAMINOPHEN 325MG | STRATEGIC SOURCING SERVICES LLC | 58780980-a5b2-5d1f-e063-6294a90a5a92 | 2026-11-05 | Warnings | 362O9ITL9D |
| Oxycodone and Acetaminophen | OXYCODONE AND ACETAMINOPHEN | American Health Packaging | 03c9ff0d-46e8-448c-944a-7ad59d1afd6d | 2026-11-05 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Acetaminophen and Caffeine | ACETAMINOPHEN AND CAFFEINE | HHH Pharmaceuticals | 6f5bfd54-b366-46ac-aafa-394e21ce8de6 | 2026-11-05 | Warnings | 3G6A5W338E 362O9ITL9D |
| Eyewash Station Additive Concentrate | CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL | Encon Safety Products, Inc. | b5a62567-c9f1-0492-e053-2a95a90ab247 | 2026-11-05 | Warnings | 6DC9Q167V3 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.